G177 Cisplatin-induced ototoxicity in paediatric and adolescent osteosarcoma patients remains a challenge

Abstract

Background/ObjectivesCisplatin-induced ototoxicity is a well-recognised complication of cancer treatment, resulting in non-reversible, often progressive hearing loss.Risk factors for cisplatin-induced hearing loss include higher cumulative cisplatin dose, younger patient age, head/neck...